Enovix Corp false 0001828318 0001828318 2021-12-07 2021-12-07 0001828318 envx:CommonStock0.0001ParValuePerShare2Member 2021-12-07 2021-12-07 0001828318 envx:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf11.50PerShare1Member 2021-12-07 2021-12-07

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 7, 2021

 

 

Enovix Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39753   85-3174357
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

3501 W. Warren Avenue
Fremont, California
  94538
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (510) 695-2350

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $0.0001 par value per share   ENVX   The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share   ENVXW   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


Item 7.01

Regulation FD Disclosure.

On December 7, 2021, Enovix Corporation (the “Company”) issued (i) a press release announcing that certain of its executive officers will present the attached presentations regarding an update on the Company’s Electric Vehicle program at the 21st Annual Advanced Automotive Battery Conference, being held December 7-9, 2021 in San Diego, California and (ii) a blog post regarding the Company’s Electric Vehicle program. The above referenced press release will be available on the investor relations section of the Company’s website (https://ir.enovix.com/) and the above referenced blog post will be available at https://enovix.medium.com/.

Copies of the above referenced press release, presentations and blog post are furnished as Exhibit 99.1, Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4, respectively, to this Current Report on Form 8-K. This information, including the information contained in the press release, presentations and blog post furnished as Exhibit 99.1, Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any of the Company’s filings, whether made before or after the date hereof, regardless of any general incorporation language in any such filing.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No.

  

Description

99.1    Press Release, dated December 7, 2021
99.2    Presentation, dated December 7, 2021: “Enovix Overview”
99.3    Presentation, dated December 7, 2021: “Enovix: From Mobile Electronics to EVs”
99.4    Blog Post, dated December 7, 2021
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 7, 2021   Enovix Corporation
  By:  

/s/ Steffen Pietzke

    Steffen Pietzke
    Chief Financial Officer